175 related articles for article (PubMed ID: 31439436)
1. Timeliness of Treatment Initiation in Newly Diagnosed Patients With Breast Cancer.
Dong J; Esham KS; Boehm L; Karim SA; Lin M; Mao D; Wang F; Fein D; Wang H; Studenmund C; Weidner RA; Noubary F; Freund KM; Erban JK; Parsons SK
Clin Breast Cancer; 2020 Feb; 20(1):e27-e35. PubMed ID: 31439436
[TBL] [Abstract][Full Text] [Related]
2. Delays in Diagnosis and Treatment of Breast Cancer: A Safety-Net Population Profile.
Jaiswal K; Hull M; Furniss AL; Doyle R; Gayou N; Bayliss E
J Natl Compr Canc Netw; 2018 Dec; 16(12):1451-1457. PubMed ID: 30545992
[No Abstract] [Full Text] [Related]
3. Association of Adjuvant Hormone Therapy Timing With Overall Survival Among Patients With Hormone Receptor-Positive Human Epidermal Growth Factor Receptor-2-Negative Early Breast Cancer Without Chemotherapy.
Fu F; Yu L; Zeng B; Chen M; Guo W; Chen L; Lin Y; Hou J; Li J; Li Y; Li S; Chen X; Zhang W; Jin X; Cai W; Zhang K; Chen H; Qiu Y; Nie Q; Wang C; Jacobs L
JAMA Netw Open; 2022 Feb; 5(2):e2145934. PubMed ID: 35166783
[TBL] [Abstract][Full Text] [Related]
4. Factors Associated With Delays in Chemotherapy Initiation Among Patients With Breast Cancer at a Comprehensive Cancer Center.
Losk K; Vaz-Luis I; Camuso K; Batista R; Lloyd M; Tukenmez M; Golshan M; Lin NU; Bunnell CA
J Natl Compr Canc Netw; 2016 Dec; 14(12):1519-1526. PubMed ID: 27956536
[TBL] [Abstract][Full Text] [Related]
5. Impact of timeliness of adjuvant chemotherapy and radiotherapy on the outcomes of breast cancer; a pooled analysis of three clinical trials.
Abdel-Rahman O
Breast; 2018 Apr; 38():175-180. PubMed ID: 29432980
[TBL] [Abstract][Full Text] [Related]
6. Clinical Characteristics and Outcomes of Single Versus Double Hormone Receptor-Positive Breast Cancer in 2 Large Databases.
Li Z; Tu Y; Wu Q; Wang Z; Li J; Zhang Y; Sun S
Clin Breast Cancer; 2020 Apr; 20(2):e151-e163. PubMed ID: 31551181
[TBL] [Abstract][Full Text] [Related]
7. Identifying factors influencing delays in breast cancer treatment in Kentucky following the 2014 Medicaid expansion.
Bhutiani N; Hicks AC; Huang B; Chen Q; Tucker TC; McMasters KM; Ajkay N
J Surg Oncol; 2020 Jun; 121(8):1191-1200. PubMed ID: 32227342
[TBL] [Abstract][Full Text] [Related]
8. Oral Endocrine Therapy Agent, Race/Ethnicity, and Time on Therapy Predict Adherence in Breast Cancer Patients in a Large Academic Institution.
Hwang GS; Paranjpe R; Opsomer C; Lu K; Abajue U; Abughosh S; Zaghloul H; Trivedi MV
Clin Breast Cancer; 2020 Dec; 20(6):520-526. PubMed ID: 32669209
[TBL] [Abstract][Full Text] [Related]
9. Treatment patterns and outcomes in older women with early breast cancer: a population-based cohort study in China.
Liu X; Zheng D; Wu Y; Luo C; Fan Y; Zhong X; Zheng H
BMC Cancer; 2021 Mar; 21(1):226. PubMed ID: 33673816
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Outcomes of Signet Ring Cell Carcinoma of the Breast.
Mehdi M; Kong AL; Frebault J; Huang S; Huang CC; Cortina CS
J Surg Res; 2021 Aug; 264():138-148. PubMed ID: 33823490
[TBL] [Abstract][Full Text] [Related]
11. Effect of Surgery Type on Time to Adjuvant Chemotherapy and Impact of Delay on Breast Cancer Survival: A National Cancer Database Analysis.
Kupstas AR; Hoskin TL; Day CN; Habermann EB; Boughey JC
Ann Surg Oncol; 2019 Oct; 26(10):3240-3249. PubMed ID: 31332635
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Quality of Adjuvant Endocrine Therapy Delivery for Breast Cancer Care in the United States.
Daly B; Olopade OI; Hou N; Yao K; Winchester DJ; Huo D
JAMA Oncol; 2017 Jul; 3(7):928-935. PubMed ID: 28152150
[TBL] [Abstract][Full Text] [Related]
13. Outcomes after mastectomy with immediate breast reconstruction for breast cancer in a multiethnic, middle-income Asian setting.
See MH; Sinnadurai S; Lai LL; Tan KL; Teh MS; Teoh LY; Jamaris S; Abdul Malik R; Bhoo-Pathy N
Surgery; 2021 Dec; 170(6):1604-1609. PubMed ID: 34538341
[TBL] [Abstract][Full Text] [Related]
14. Population-Based Study on Cancer Subtypes, Guideline-Concordant Adjuvant Therapy, and Survival Among Women With Stage I-III Breast Cancer.
Hsieh MC; Zhang L; Wu XC; Davidson MB; Loch M; Chen VW
J Natl Compr Canc Netw; 2019 Jun; 17(6):676-686. PubMed ID: 31200362
[TBL] [Abstract][Full Text] [Related]
15. Ductal Carcinoma in Situ: A French National Survey. Analysis of 2125 Patients.
Cutuli B; Lemanski C; De Lafontan B; Chauvet MP; De Lara CT; Mege A; Fric D; Richard-Molard M; Mazouni C; Cuvier C; Carre A; Kirova Y
Clin Breast Cancer; 2020 Apr; 20(2):e164-e172. PubMed ID: 31780381
[TBL] [Abstract][Full Text] [Related]
16. Clinical Impact of 21-Gene Recurrence Score Test Within the Veterans Health Administration: Utilization and Receipt of Guideline-Concordant Care.
Hull LE; Lynch JA; Berse BB; DuVall SL; Chun DS; Venne VL; Efimova OV; Icardi MS; Kelley MJ
Clin Breast Cancer; 2018 Apr; 18(2):135-143. PubMed ID: 29306660
[TBL] [Abstract][Full Text] [Related]
17. Adherence to Adjuvant Endocrine Therapy in Insured Black and White Breast Cancer Survivors: Exploring Adherence Measures in Patient Data.
Sheppard VB; He J; Sutton A; Cromwell L; Adunlin G; Salgado TM; Tolsma D; Trout M; Robinson BE; Edmonds MC; Bosworth HB; Tadesse MG
J Manag Care Spec Pharm; 2019 May; 25(5):578-586. PubMed ID: 31039059
[TBL] [Abstract][Full Text] [Related]
18. Impact of Genomic Assay Testing and Clinical Factors on Chemotherapy Use After Implementation of Standardized Testing Criteria.
Natsuhara KH; Losk K; King TA; Lin NU; Camuso K; Golshan M; Pochebit S; Brock JE; Bunnell CA; Freedman RA
Oncologist; 2019 May; 24(5):595-602. PubMed ID: 30076279
[TBL] [Abstract][Full Text] [Related]
19. Genome Instability Profiles Predict Disease Outcome in a Cohort of 4,003 Patients with Breast Cancer.
Lischka A; Doberstein N; Freitag-Wolf S; Koçak A; Gemoll T; Heselmeyer-Haddad K; Ried T; Auer G; Habermann JK
Clin Cancer Res; 2020 Sep; 26(17):4606-4615. PubMed ID: 32522886
[TBL] [Abstract][Full Text] [Related]
20. Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer Patients.
Cantini L; Pistelli M; Merloni F; Fontana A; Bertolini I; De Angelis C; Bastianelli L; Della Mora A; Santinelli A; Savini A; Maccaroni E; Diodati L; Falcone A; Berardi R
Clin Breast Cancer; 2020 Feb; 20(1):e89-e98. PubMed ID: 31378534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
